Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death?
Recent clinical trials indicate that approximately two-thirds of patients in New York Heart Association (NYHA) class II and III, who comprise almost 90% of patients with heart failure, die suddenly. Patients in NYHA class IV usually die of progressive heart failure. Implantation of implantable cardi...
Kaydedildi:
| Yayımlandı: | Curr Control Trials Cardiovasc Med |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2000
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59608/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11714419/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-1-2-095 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|